MAP2K3 and colorectal carcinoma: Results demonstrated that, also in tested CRC cells, MKK3 interacts and complexes to AURKA (Fig. 4A), however the MKK3/AURKA protein–protein interaction was not perturbed by AT9283 treatments in both tested CRC line (Fig. 4A).